TherapeuticsMD (TXMD)
TherapeuticsMD on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
25K
Short interest
settlement 2026-10-15
1.4
Days to cover
unchanged vs prior
33.2%
Short share of volume
2026-11-02
193
Fails to deliver
settlement 2026-10-14
Thu 12 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in TXMD is 24,664 shares, down 1,773 shares over the last month. Over the last 48 readings it ranged from 11,980 shares (31 December 2024) to 240,204 shares (15 January 2025). The latest reading sits at the bottom of that range. At the reported average volume of 17K shares a day that is 1.4 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/txmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 24,664 | +4.2% | 17,330 | 1.42 |
| 2026-09-30 | 23,663 | -10.5% | 17,014 | 1.39 |
| 2026-09-15 | 26,437 | +0.2% | 20,859 | 1.27 |
| 2026-08-31 | 26,387 | -4.5% | 46,926 | 1.00 |
| 2026-08-14 | 27,618 | -5.2% | 14,982 | 1.84 |
| 2026-07-31 | 29,141 | -32.5% | 21,417 | 1.36 |
| 2026-07-15 | 43,171 | -23.7% | 27,388 | 1.58 |
| 2026-06-30 | 56,548 | +22.5% | 36,355 | 1.56 |
| 2026-06-15 | 46,148 | -10.2% | 100,011 | 1.00 |
| 2026-05-29 | 51,412 | -3.1% | 15,712 | 3.27 |
| 2026-05-15 | 53,083 | -6.5% | 22,738 | 2.33 |
| 2026-04-30 | 56,765 | +8.8% | 20,835 | 2.72 |
| 2026-04-15 | 52,193 | +8.1% | 24,451 | 2.13 |
| 2026-03-31 | 48,285 | +1.6% | 21,428 | 2.25 |
| 2026-03-13 | 47,542 | +5.3% | 23,836 | 1.99 |
| 2026-02-27 | 45,159 | -4.4% | 20,211 | 2.23 |
| 2026-02-13 | 47,244 | -0.8% | 49,145 | 1.00 |
| 2026-01-30 | 47,648 | -45.5% | 145,898 | 1.00 |
| 2026-01-15 | 87,461 | +39.4% | 195,705 | 1.00 |
| 2025-12-31 | 62,745 | -6.9% | 51,689 | 1.21 |
| 2025-12-15 | 67,400 | +19.7% | 65,756 | 1.03 |
| 2025-11-28 | 56,298 | -19.0% | 173,397 | 1.00 |
| 2025-11-14 | 69,507 | -47.3% | 167,041 | 1.00 |
| 2025-10-31 | 131,805 | +280.2% | 835,892 | 1.00 |
| 2025-10-15 | 34,664 | -10.9% | 20,487 | 1.69 |
| 2025-09-30 | 38,922 | +0.5% | 12,916 | 3.01 |
| 2025-09-15 | 38,730 | +93.7% | 21,183 | 1.83 |
| 2025-08-29 | 19,999 | -18.5% | 13,010 | 1.54 |
| 2025-08-15 | 24,546 | +17.9% | 19,475 | 1.26 |
| 2025-07-31 | 20,818 | +15.0% | 26,976 | 1.00 |
| 2025-07-15 | 18,102 | -20.1% | 29,047 | 1.00 |
| 2025-06-30 | 22,665 | -45.6% | 43,075 | 1.00 |
| 2025-06-13 | 41,643 | -50.4% | 102,075 | 1.00 |
| 2025-05-30 | 83,865 | -7.4% | 23,053 | 3.64 |
| 2025-05-15 | 90,601 | -23.3% | 52,861 | 1.71 |
| 2025-04-30 | 118,076 | -19.4% | 38,017 | 3.11 |
| 2025-04-15 | 146,481 | -13.4% | 33,174 | 4.42 |
| 2025-03-31 | 169,192 | -0.6% | 56,717 | 2.98 |
| 2025-03-14 | 170,162 | -19.2% | 79,951 | 2.13 |
| 2025-02-28 | 210,509 | +35.2% | 1,713,096 | 1.00 |
| 2025-02-14 | 155,753 | -10.4% | 33,791 | 4.61 |
| 2025-01-31 | 173,801 | -27.6% | 64,988 | 2.67 |
| 2025-01-15 | 240,204 | +1905.0% | 1,814,375 | 1.00 |
| 2024-12-31 | 11,980 | -43.7% | 83,062 | 1.00 |
| 2024-12-13 | 21,273 | +0.9% | 15,604 | 1.36 |
| 2024-11-29 | 21,081 | -30.0% | 24,493 | 1.00 |
| 2024-11-15 | 30,126 | +1.3% | 20,870 | 1.44 |
| 2024-10-31 | 29,735 | +26.6% | 15,038 | 1.98 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of TXMD volume is 33.2%, down 29.0 points over the last five sessions. Over the last 30 readings it ranged from 0.5% (30 October 2026) to 66.5% (22 September 2026). The latest reading is 4.9 points below the 30-session average of 38.1%, on 4K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 1K | 4K | 33.2% | 0 |
| 2026-10-30 | 6 | 1K | 0.5% | 0 |
| 2026-10-29 | 1K | 3K | 40.0% | 0 |
| 2026-10-28 | 12K | 18K | 66.2% | 0 |
| 2026-10-27 | 2K | 4K | 47.2% | 68 |
| 2026-10-26 | 2K | 3K | 62.2% | 0 |
| 2026-10-23 | 4K | 10K | 46.7% | 0 |
| 2026-10-22 | 2K | 4K | 55.7% | 0 |
| 2026-10-21 | 1K | 5K | 27.7% | 119 |
| 2026-10-20 | 2K | 5K | 44.8% | 50 |
| 2026-10-19 | 35K | 90K | 38.8% | 0 |
| 2026-10-16 | 921 | 5K | 18.9% | 0 |
| 2026-10-15 | 2K | 8K | 27.2% | 0 |
| 2026-10-14 | 639 | 2K | 28.2% | 0 |
| 2026-10-13 | 3K | 12K | 23.2% | 0 |
| 2026-10-12 | 1K | 4K | 24.6% | 0 |
| 2026-10-09 | 3K | 5K | 54.8% | 0 |
| 2026-10-08 | 2K | 7K | 29.4% | 0 |
| 2026-10-07 | 8K | 24K | 34.0% | 0 |
| 2026-10-06 | 2K | 5K | 36.6% | 0 |
| 2026-10-05 | 4K | 9K | 51.5% | 0 |
| 2026-10-02 | 856 | 5K | 18.4% | 0 |
| 2026-10-01 | 3K | 6K | 47.0% | 0 |
| 2026-09-30 | 1K | 2K | 53.9% | 0 |
| 2026-09-29 | 1K | 5K | 24.2% | 0 |
| 2026-09-28 | 3K | 8K | 41.1% | 0 |
| 2026-09-25 | 986 | 8K | 12.9% | 0 |
| 2026-09-24 | 2K | 6K | 42.7% | 0 |
| 2026-09-23 | 6K | 14K | 44.3% | 0 |
| 2026-09-22 | 6K | 9K | 66.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in TXMD is 193 shares, down 342 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (11 March 2026) to 185,482 shares (14 January 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 193 | $1.96 | $378 |
| 2026-10-13 | 535 | $2.02 | $1K |
| 2026-09-21 | 54 | $2.19 | $118 |
| 2026-09-18 | 19 | $2.18 | $41 |
| 2026-07-06 | 2 | $2.11 | $4 |
| 2026-06-30 | 50 | $2.24 | $112 |
| 2026-06-25 | 1,041 | $2.01 | $2K |
| 2026-05-27 | 139 | $2.11 | $293 |
| 2026-05-19 | 354 | $2.02 | $715 |
| 2026-05-05 | 90 | $2.02 | $182 |
| 2026-04-28 | 217 | $2.07 | $449 |
| 2026-03-30 | 140 | $2.10 | $294 |
| 2026-03-19 | 163 | $2.22 | $362 |
| 2026-03-17 | 84 | $2.17 | $182 |
| 2026-03-13 | 1,410 | $2.28 | $3K |
| 2026-03-11 | 2 | $2.30 | $5 |
| 2026-01-26 | 2,169 | $2.61 | $6K |
| 2026-01-15 | 25,133 | $2.14 | $54K |
| 2026-01-14 | 185,482 | $2.10 | $390K |
| 2025-12-24 | 7,336 | $1.64 | $12K |
| 2025-12-02 | 40 | $1.52 | $61 |
| 2025-11-13 | 1,402 | $1.68 | $2K |
| 2025-11-05 | 188 | $1.16 | $218 |
| 2025-10-27 | 315 | $1.29 | $406 |
| 2025-10-22 | 2,488 | $1.17 | $3K |
| 2025-10-20 | 880 | $1.25 | $1K |
| 2025-09-17 | 110 | $1.08 | $119 |
| 2025-08-01 | 5,314 | $1.12 | $6K |
| 2025-07-31 | 20 | $1.13 | $23 |
| 2025-07-28 | 314 | $1.19 | $374 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for TXMD in the last 90 days. The most recent filings are listed below. Latest filing: Thompson Tommy G (Director) on 2025-12-23.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Thompson Tommy G | Director | Buy | 8K | $1.67 | $14K | 23K |
| 2025-04-14 | Walker Marlan D | Chief Executive Officer | Buy | 490 | $1.00 | $490 | 74K |
| 2025-04-14 | Thompson Tommy G | Director | Buy | 325 | $1.00 | $325 | 15K |
| 2025-04-10 | Walker Marlan D | Chief Executive Officer | Buy | 1K | $0.86 | $1K | 73K |
| 2025-04-09 | Walker Marlan D | Chief Executive Officer | Buy | 1K | $0.87 | $988 | 72K |
| 2025-02-18 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 3K | $0.00 | $0 | 66K |
| 2025-02-18 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 68K |
| 2025-02-18 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 71K |
| 2025-02-18 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 770 | $0.00 | $0 | 69K |
| 2025-02-18 | Thompson Tommy G | Director | Exercise or conversion | 9K | $0.00 | $0 | 14K |
| 2025-02-18 | Naughton Gail K | Director | Exercise or conversion | 9K | $0.00 | $0 | 9K |
| 2025-02-18 | Collins Cooper C. | Director | Exercise or conversion | 9K | $0.00 | $0 | 61K |
| 2024-08-22 | Collins Cooper C. | Director | Buy | 4K | $1.73 | $7K | 52K |
| 2024-08-21 | Collins Cooper C. | Director | Buy | 1K | $1.70 | $2K | 48K |
| 2023-12-07 | Walker Marlan D | Chief Executive Officer | Sell | 5K | $2.24 | $10K | 63K |
| 2023-12-06 | Walker Marlan D | Chief Executive Officer | Sell | 15K | $2.31 | $33K | 67K |
| 2023-12-05 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 70K | $0.00 | $0 | 82K |
| 2023-11-15 | Rosen David Efraim | TenPercentOwner | Grant | 877K | $2.28 | $2.0M | 2.9M |
| 2023-08-17 | ZIEGLER JOSEPH | Principal Financial Officer | Grant | 8K | $0.00 | $0 | 8K |
| 2023-06-28 | Rosen David Efraim | Director,TenPercentOwner,Other | Grant | 313K | $3.68 | $1.2M | 2.1M |
| 2023-04-26 | Walker Marlan D | Chief Executive Officer | Sell | 692 | $3.64 | $3K | 12K |
| 2023-04-26 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 1K | $0.00 | $0 | 14K |
| 2023-04-26 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 12K |
| 2023-04-12 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 12K |
| 2023-04-12 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 50K | $0.00 | $0 | 62K |
| 2023-04-12 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 3K | $0.00 | $0 | 9K |
| 2023-04-12 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 1K | $0.00 | $0 | 10K |
| 2023-04-12 | Walker Marlan D | Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 13K |
| 2023-04-12 | Walker Marlan D | Chief Executive Officer | Sell | 1K | $3.65 | $4K | 12K |
| 2023-01-27 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 49 | $5.09 | $249 | 12K |
| 2023-01-26 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 2K | $0.00 | $0 | 10K |
| 2023-01-26 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 1K | $0.00 | $0 | 14K |
| 2023-01-26 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 2K | $5.08 | $8K | 12K |
| 2023-01-26 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 2K | $0.00 | $0 | 12K |
| 2023-01-24 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 7 | $5.31 | $37 | 8K |
| 2023-01-23 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 519 | $0.00 | $0 | 7K |
| 2023-01-23 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 380 | $0.00 | $0 | 5K |
| 2023-01-23 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2023-01-23 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 1K | $5.34 | $7K | 8K |
| 2023-01-23 | Donegan Michael C | Prin. Fin. and Acctg. Officer | Exercise or conversion | 2K | $0.00 | $0 | 9K |
| 2022-12-30 | Rubric Capital Management LP | TenPercentOwner | Sell | 29K | $1333.00 | $38.7M | 0 |
| 2022-12-30 | Rubric Capital Management LP | Director,TenPercentOwner,Other | Returned to company | 29K | $1333.00 | $38.7M | 0 |
| 2022-12-09 | Bernick Brian | Co-Chief Executive Officer | Sell | 320 | $6.31 | $2K | 4K |
| 2022-12-09 | Rubric Capital Management LP | TenPercentOwner | Buy | 15K | $6.09 | $90K | 1.8M |
| 2022-12-08 | Rosen David Efraim | TenPercentOwner | Buy | 300 | $5.83 | $2K | 1.7M |
| 2022-12-07 | Naughton Gail K | Director | Sell | 4K | $5.26 | $21K | 0 |
| 2022-12-07 | Rosen David Efraim | TenPercentOwner | Buy | 20K | $5.66 | $114K | 1.7M |
| 2022-12-06 | Donegan Michael C | Interim CFO/CAO/VP of Finance | Exercise or conversion | 2K | $0.00 | $0 | 4K |
| 2022-12-06 | Donegan Michael C | Interim CFO/CAO/VP of Finance | Exercise or conversion | 380 | $0.00 | $0 | 5K |
| 2022-12-06 | Donegan Michael C | Interim CFO/CAO/VP of Finance | Exercise or conversion | 534 | $0.00 | $0 | 5K |
| 2022-12-06 | Donegan Michael C | Interim CFO/CAO/VP of Finance | Sell | 910 | $4.78 | $4K | 5K |
| 2022-12-06 | Donegan Michael C | Interim CFO/CAO/VP of Finance | Exercise or conversion | 262 | $0.00 | $0 | 5K |
| 2022-12-06 | Glickman Mark A | Co-Chief Executive Officer | Exercise or conversion | 2K | $0.00 | $0 | 2K |
| 2022-12-06 | Glickman Mark A | Co-Chief Executive Officer | Sell | 440 | $4.92 | $2K | 1K |
| 2022-12-06 | Walker Marlan D | General Counsel | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2022-12-06 | Walker Marlan D | General Counsel | Exercise or conversion | 388 | $0.00 | $0 | 8K |
| 2022-12-06 | Walker Marlan D | General Counsel | Sell | 1K | $4.95 | $5K | 7K |
| 2022-12-06 | Walker Marlan D | General Counsel | Exercise or conversion | 1K | $0.00 | $0 | 7K |
| 2022-12-06 | Bernick Brian | Co-Chief Executive Officer | Sell | 935 | $4.92 | $5K | 4K |
| 2022-12-06 | Bernick Brian | Co-Chief Executive Officer | Exercise or conversion | 3K | $0.00 | $0 | 5K |
| 2022-10-28 | Rubric Capital Management LP | TenPercentOwner | Buy | 7K | $1000.00 | $7.0M | 29K |
| 2022-09-30 | Rubric Capital Management LP | TenPercentOwner | Buy | 7K | $1000.00 | $7.0M | 22K |
| 2022-08-18 | BISARO PAUL | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 6K |
| 2022-08-18 | Thompson Tommy G | Director | Exercise or conversion | 3K | price not stated in the filing | not stated | 6K |
| 2022-08-18 | Ling Karen | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 5K |
| 2022-08-18 | Russell Angus C. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 6K |
| 2022-08-18 | MUSING JULES A. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 4K |
| 2022-08-18 | Naughton Gail K | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 4K |
| 2022-08-18 | Collins Cooper C. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 47K |
| 2022-07-29 | Rosen David Efraim | TenPercentOwner | Buy | 565K | $4.72 | $2.7M | 1.7M |
| 2022-07-29 | Rosen David Efraim | TenPercentOwner | Buy | 15K | $822.21 | $12.3M | 15K |
| 2022-07-18 | Rosen David Efraim | TenPercentOwner | Buy | 18K | $6.03 | $107K | 1.2M |
| 2022-07-15 | Rosen David Efraim | TenPercentOwner | Buy | 65K | $5.56 | $361K | 1.1M |
| 2022-03-14 | Walker Marlan D | General Counsel | Exercise or conversion | 230K | price not stated in the filing | not stated | 259K |
| 2021-11-30 | Donegan Michael C | CAO and VP of Finance | Exercise or conversion | 115K | price not stated in the filing | not stated | 129K |
| 2021-11-30 | Donegan Michael C | CAO and VP of Finance | Sell | 30K | $0.54 | $16K | 99K |
| 2021-11-18 | Collins Cooper C. | Director | Buy | 1.0M | $0.58 | $580K | 2.2M |
| 2021-08-18 | Collins Cooper C. | Director | Buy | 900K | $0.72 | $648K | 1.2M |
| 2021-08-17 | Collins Cooper C. | Director | Buy | 100K | $0.77 | $77K | 337K |
| 2021-08-17 | Ling Karen | Director | Buy | 33K | $0.75 | $25K | 130K |
| 2021-08-16 | BISARO PAUL | Director | Buy | 50K | $0.79 | $40K | 197K |
| 2021-08-13 | Thompson Tommy G | Director | Buy | 11K | $0.87 | $10K | 716K |
| 2021-08-12 | DArecca James | Chief Financial Officer | Sell | 93K | $0.87 | $81K | 124K |
| 2021-08-10 | Ling Karen | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 97K |
| 2021-08-10 | CARROLL J MARTIN | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 107K |
| 2021-08-10 | Thompson Tommy G | Director | Exercise or conversion | 145K | price not stated in the filing | not stated | 149K |
| 2021-08-10 | Collins Cooper C. | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 237K |
| 2021-08-10 | DArecca James | Chief Financial Officer | Exercise or conversion | 217K | price not stated in the filing | not stated | 217K |
| 2021-08-10 | MUSING JULES A. | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 102K |
| 2021-08-10 | BISARO PAUL | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 147K |
| 2021-08-10 | Russell Angus C. | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 190K |
| 2021-08-10 | Naughton Gail K | Director | Exercise or conversion | 97K | price not stated in the filing | not stated | 97K |
| 2021-05-14 | Thompson Tommy G | Director | Buy | 5K | $1.06 | $5K | 705K |
| 2021-05-11 | Finizio Robert G | CEO | Sell | 68K | $1.04 | $70K | 18.0M |
| 2021-05-11 | Milligan John C.K. IV | Secretary/CEO of subsidiary | Sell | 44K | $1.04 | $46K | 1.8M |
| 2021-05-11 | BORKOWSKI EDWARD | EVP, Operations | Sell | 44K | $1.04 | $46K | 59K |
| 2021-05-11 | Walker Marlan D | General Counsel | Sell | 22K | $1.04 | $22K | 29K |
| 2021-05-11 | Donegan Michael C | CAO and VP Finance | Sell | 5K | $1.04 | $5K | 14K |
| 2021-05-10 | Finizio Robert G | CEO | Exercise or conversion | 158K | price not stated in the filing | not stated | 18.1M |
| 2021-05-10 | Milligan John C.K. IV | Secretary/CEO of subsidiary | Exercise or conversion | 104K | price not stated in the filing | not stated | 1.8M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of TXMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Baselake Partners, LP at 6.8% of the class (790,703 shares), filed 2026-08-05 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-05 | 13G/Ano. 1 | Baselake Partners, LPpartnership | 791K | 6.8% | 2026-06-30 |
| 2026-08-05 | 13G/Ano. 1 | Baselake Management, LLCinvestment adviser, other entity | 791K | 6.8% | 2026-06-30 |
| 2026-08-05 | 13G/Ano. 1 | David Paolellaparent holding company, individual | 791K | 6.8% | 2026-06-30 |
13F holders
Tracked managers holding TXMD at their latest 13F. JSON2 of the 30 tracked managers held TXMD at their latest 13F, $514K in total at quarter-end prices. Renaissance Technologies is the largest at $324K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 147K | $324K | 0.00% | +399 |
| Citadel Advisors | 2026-06-30 | 86K | $190K | 0.00% | +18K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
TherapeuticsMD in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows TherapeuticsMD (TXMD), SEC CIK 25743, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-05.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-11.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-12-23.JSON and CSV
- Company record
- EDGAR filing index for CIK 25743Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of TXMD is sold short?
24,664 shares were held short at the 2026-10-15 settlement, 1.4 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TXMD's daily short volume?
On 2026-11-02, 1,373 of the 4,136 TXMD shares reported to FINRA were sold short, 33.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TXMD have fails to deliver?
The SEC's latest file shows 193 TXMD shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are TXMD insiders buying or selling?
No open-market insider trades were reported for TXMD in the last 90 days. The most recent filings are listed below. Latest filing: Thompson Tommy G (Director) on 2025-12-23.
Who owns 5% or more of TXMD?
3 holders report 5% or more of TXMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Baselake Partners, LP at 6.8% of the class (790,703 shares), filed 2026-08-05 for an event on 2026-06-30.
Which tracked 13F managers own TXMD?
2 of the 30 tracked 13F managers held TXMD shares at their latest filing, $514K in all. The largest: Renaissance Technologies (147K shares, $324K), Ken Griffin's Citadel Advisors (86K shares, $190K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.